الفهرس 
cover EnglishOnly 14 pages are availabe for public view
 |  | from | 156 |  |  |
| | | from | 156 | | |
Abstract
Breast cancer (BC) is a heterogeneous disease that encompasses several distinct entities with different biological characteristics and clinical behavior. The purpose of this study is to correlate between the outcome of early breast cancer patients who received anthracycline-based chemotherapy with the tumor receptor status namely estrogen, progesterone and HER-2 receptor as regard disease free survival and overall survival.